
Want to protect yourself against cancer? Get vaccinated
Many cancers associated with infection are preventable

Want to protect yourself against cancer? Get vaccinated
Many cancers associated with infection are preventable

Blood test for multiple cancers clears crucial hurdle on track to FDA approval
If approved, the test could help catch cancers early—but more research is still needed, experts say


Blood test shows promise in detecting pancreatic cancer early—a ‘holy grail’ for the field
Pancreatic cancer is typically caught in its latest stages, when it is hardest to treat

‘Unparalleled’ study finds psilocybin protects against nerve damage from chemotherapy
The findings, which were made in mice, may offer a new way to prevent a common chemotherapy side effect that can last well beyond treatment

U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease
Pancreatic cancer is considered one of the hardest to treat and most serious forms of cancer

‘Landmark’ trial shows mRNA therapy significantly cuts the odds of recurrent skin cancer
The combined drug works by nudging the body’s own immune system to make proteins that attack and destroy melanoma cells

Experimental immune therapy shows promise against deadly childhood brain cancer
Several children who had aggressive recurrent brain tumors remained disease-free years after this treatment, according to an early-stage trial

How viruses may reshape the body’s ‘soil’ to promote cancer growth
Everyday viral infections may be quietly reshaping the body’s network of molecules that support cells and tissues in ways that can raise cancer risk over time

Proposed White House regulations could kill 5,000 clinical trials, analysis finds
The Trump administration is mulling new rules that would give political appointees final say on research grants

Jaye Gardiner
Learning how the matrix around cells and tissues impacts cancers

Mikhail Kolmogorov
Developing software to reveal large genetic changes that lead to cancer

Chris Boshoff
The Pfizer executive talks about rekindling the public’s excitement over science